This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 07 Jun 2019  |  Asia Pacific  |  Market Research

    Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023

    The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market

    This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

    $3,000.00
  2. 04 Apr 2019  |  Asia Pacific  |  Market Research

    Chinese Clinical Laboratories Market, Forecast to 2025

    Investment in Private and Specialty Care Clinics Drives Growth

    China is one of the fastest growing healthcare markets in the world. Traditionally, healthcare services have been dominated by the public sector; however, 2014 onward, the trend reversed with greater private sector participation. China still faces a number of challenges: unequal distribution of healthcare resources across the country; lack of an ef...

    $1,500.00
  3. 01 Apr 2019  |  Asia Pacific  |  Market Research

    Vietnamese Clinical Laboratories Market, Forecast to 2025

    Increase in Universal Health Support for Private Healthcare will Boost Test Volumes in Both Public and Private Sectors

    Clinical laboratories are an essential part of the health industry. Approximately 80% of physicians' diagnoses is estimated to be the result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare application in favor of the laboratory, making it a more valuable part of the treatment plan. Vietnam CLT marke...

    $1,500.00
  4. 28 Mar 2019  |  Asia Pacific  |  Market Research

    Malaysian Clinical Laboratories Market, Forecast to 2025

    Shift toward Preventive Healthcare is Driving Market Growth

    The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...

    $1,500.00
  5. 28 Mar 2019  |  Asia Pacific  |  Market Research

    Thailand Clinical Laboratories Market, Forecast to 2025

    Rising Demand for Diagnostics Services from the Ageing Population and Growing Prevalence of Chronic Diseases to Drive Market Growth

    This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...

    $1,500.00
  6. 19 Dec 2014  |  Asia Pacific  |  Market Research

    Patent Cliff and the Future of Generics in Asia

    Trends that will Impact the Market in the Short Term

    The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

    $2,450.00
  7. 15 Nov 2014  |  Asia Pacific  |  Market Research

    Thailand In Vitro Diagnostics Market

    Snapshot of Demand and Investment Opportunities

    The report is expected to support the strategic decision makers in the In Vitro Diagnostic (IVD) market that are either planning to expand or enter Thailand. The forecast of the major segments can help the diagnostic companies decide their next five years business plan. Segments in the market include molecular diagnostics, immunochemistry, and mic...

    $2,450.00
  8. 17 Sep 2014  |  Asia Pacific  |  Market Research

    Analysis of the Chinese Breast Imaging Systems Market

    Technology Enhancements Accelerate the Growth of Diagnostic Imaging

    This research service provides the market revenues and trends of various breast imaging modalities in the Chinese market. Increasing incidence of breast cancer, awareness among the population, healthcare reforms, and expansion of breast screening to rural areas accelerate the growth of breast imaging market in China. Increasing disposable income, ...

    $3,950.00
  9. 12 Aug 2014  |  Asia Pacific  |  Market Research

    Malaysia Healthcare Outlook

    Showcasing Value Propositions for Investors

    The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...

    $3,950.00
  10. This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

    $500.00